For patients with type 2 diabetes, their healthcare provider will most commonly prescribe Ozempic, which was created specifically to help with processing insulin and lowering blood sugar levels
The program was launched in early 2024 and expanded through 2025
Along with the rapid weight loss associated with GLP-1s, muscle mass and VO2maxtwo indicators of longevityoften decrease
You may be eligible if at least one of these is true: You have a Body Mass Index (BMI) of 35 or higher Your BMI is 30 or higher, and you have certain types of heart failure OR high blood pressurethat's hard to control OR chronic kidney disease (stage 3a or above) Your BMI is 27 or higher, and you have prediabetes OR you've had a heart attack, stroke, orblocked arteries in your legs or arms Patients with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease should contact their Medicare drug plan, as they may already cover a GLP-1 drug outside of this program
Fermented dairy and targeted probiotics Yogurt, kefir and some fermented dairy products can shift gut ecology and modestly increase GLP-1 or improve post-meal glucose control in some trials
Furthermore, it explores the potential value and current controversies surrounding its prophylactic application